Literature DB >> 23324736

Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis.

Cristiane Kayser1, Juliana Y Sekiyama, Lucas C Próspero, Cintia Z Camargo, Luis E C Andrade.   

Abstract

OBJECTIVES: Peripheral microangiopathy is a hallmark of systemic sclerosis (SSc) and can be early detected by nailfold capillaroscopy (NFC). This study aimed to examine whether more severe peripheral microangiopathy at NFC are predictive factor for death in SSc patients.
METHODS: 135 SSc patients who performed NFC between June 2001 and July 2009 were included. The following NFC parameters were evaluated: number of capillary loops/mm, avascular score (scored from 0 to 3), and number of enlarged and giant capillary loops. Univariate and multivariate regression models were used to analyse the association of mortality with NFC and clinical parameters.
RESULTS: At the time of the analysis (August 2010), 123 patients were alive, and 12 were dead. By univariate analysis, male gender, forced vital capacity <75% predicted, higher number of giant capillary loops, and an avascular score >1.5 on NFC were associated with a significantly increase risk of death. By multivariate analysis, an avascular score >1.5 was the only independent predictor of death (hazard ratio 2.265). Survival rates from diagnosis at 1, 5 and 10 years were lower in patients with avascular score >1.5 (97%, 86%, and 59%, respectively) compared with those with avascular score ≤1.5 (97%, 97%, and 91% respectively) (p=0.009 by log rank test).
CONCLUSIONS: Avascular scores higher than 1.5 at NFC was an independent predictor of death in SSc, suggesting that NFC can be useful for predicting SSc outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23324736

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis.

Authors:  Thais Rohde Pavan; Markus Bredemeier; Vanessa Hax; Karina Gatz Capobianco; Rafael da Silva Mendonça Chakr; Ricardo Machado Xavier
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

Review 2.  Treatment of early diffuse systemic sclerosis skin disease.

Authors:  Tracy M Frech; Victoria K Shanmugam; Ami A Shah; Shervin Assassi; Jessica K Gordon; Faye N Hant; Monique E Hinchcliff; Virginia Steen; Dinesh Khanna; Cristiane Kayser; Robyn T Domsic
Journal:  Clin Exp Rheumatol       Date:  2013-07-23       Impact factor: 4.473

3.  Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.

Authors:  Mengguo Liu; Ji Yang; Ming Li
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

4.  Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.

Authors:  Mengguo Liu; Ji Yang; Xiaojing Xing; Xiangxiang Cui; Ming Li
Journal:  Arthritis Res Ther       Date:  2014-12-31       Impact factor: 5.156

Review 5.  Recognizing systemic sclerosis: comparative analysis of various sets of classification criteria.

Authors:  Katarzyna Romanowska-Próchnicka; Marcela Walczyk; Marzena Olesińska
Journal:  Reumatologia       Date:  2016-12-30

6.  Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.

Authors:  Maurizio Cutolo; Ariane L Herrick; Oliver Distler; Mike O Becker; Emma Beltran; Patrick Carpentier; Clodoveo Ferri; Murat Inanç; Panayiotis Vlachoyiannopoulos; Harbajan Chadha-Boreham; Emmanuelle Cottreel; Thomas Pfister; Daniel Rosenberg; Juan V Torres; Vanessa Smith
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.